Related references
Note: Only part of the references are listed.Whole-body organ-level and kidney micro-dosimetric evaluations of 64Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin (64Cu-MM-302) in rodents and primates
Daniel F. Gaddy et al.
EJNMMI RESEARCH (2015)
Llama Antibody Fragments Have Good Potential for Application as HIV Type 1 Topical Microbicides
Andrea Gorlani et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
Laura E. McCoy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Liposomes for HIV prophylaxis
Nikita K. Malavia et al.
BIOMATERIALS (2011)
Antibody Response to Polyhistidine-Tagged Peptide and Protein Antigens Attached to Liposomes via Lipid-Linked Nitrilotriacetic Acid in Mice
Douglas S. Watson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Nanotechnology applications for improved delivery of antiretroviral drugs to the brain
Ho Lun Wong et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1
Willie W. L. Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Downregulation of EGFR by a novel multivalent nanobody-liposome platform
Sabrina Oliveira et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles
Jose das Neves et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Few and Far Between: How HIV May Be Evading Antibody Avidity
Joshua S. Klein et al.
PLOS PATHOGENS (2010)
Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes
Reginald Clayton et al.
ANTIVIRAL RESEARCH (2009)
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10
Joshua S. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail
Ajay K. Bhatia et al.
VIROLOGY (2009)
Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120
Anna Forsman et al.
JOURNAL OF VIROLOGY (2008)
Molecular architecture of native HIV-1 gp120 trimers
Jun Liu et al.
NATURE (2008)
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs
Gigi N. C. Chiu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Distribution and three-dimensional structure of AIDS virus envelope spikes
Ping Zhu et al.
NATURE (2006)
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody
MY Zhang et al.
JOURNAL OF VIROLOGY (2004)
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
G Ofek et al.
JOURNAL OF VIROLOGY (2004)
Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions
P Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1
AF Labrijn et al.
JOURNAL OF VIROLOGY (2003)
The dawning era of polymer therapeutics
R Duncan
NATURE REVIEWS DRUG DISCOVERY (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
E Chertova et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
